Bordetella Pertussis, Whooping Cough

Respiratory
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Sanofi
SanofiPARIS, France
2 programs
Nasopharyngeal samplingN/A1 trial
Strain isolation from the nasopharynxN/A1 trial
Active Trials
NCT03388034Completed789Est. Jul 2021
NCT03197597Completed265Est. Dec 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SanofiNasopharyngeal sampling
SanofiStrain isolation from the nasopharynx

Clinical Trials (2)

Total enrollment: 1,054 patients across 2 trials

NCT03388034SanofiNasopharyngeal sampling

Pertussis Immunization Programs in Low Income Countries - Ivory Coast

Start: Apr 2019Est. completion: Jul 2021789 patients
N/ACompleted
NCT03197597SanofiStrain isolation from the nasopharynx

EUpertstrain 4 Study of Bordetella Pertussis Isolates

Start: Oct 2015Est. completion: Dec 2016265 patients
N/ACompleted

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space